RI
Insider
Robert Iannone
EVP, Global Head of R&D & CMORobert Iannone (EVP, Global Head of R&D & CMO) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Jazz Pharmaceuticals plc (JAZZ). The largest single filing was $19.1M of JAZZ (76,621 sh across 5 lots, as filed), executed Aug 27.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$20.3M
shares × price, as filed
Last traded
Aug 27
Filed Aug 31
Median ADV $210.9M across their filed names
Open performance→Volume by month
Buys $0
Sells $21.6M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
JAZZRecent filings
JAZZSALE
Jazz Pharmaceuticals plc
View filing →
$19.1M76,621 sh across 5 lots
Exec Aug 27
Filed Aug 31 · 6:45 PM ET JAZZSALE Jazz Pharmaceuticals plc View filing → $1.2M
7,159 sh × $168.26
Exec Nov 17 2025
Filed Nov 19 2025 · 5:30 PM ET JAZZSALE Jazz Pharmaceuticals plc View filing → $333K
2,403 sh × $138.41
Exec Mar 10 2025
Filed Mar 12 2025 · 5:30 PM ET JAZZSALE Jazz Pharmaceuticals plc View filing → $981K
7,080 sh across 2 lots
Exec Mar 7 2025
Filed Mar 7 2025 · 5:30 PM ET